RJFSA
VIRX

Raymond James Financial Services Advisors’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Raymond James Financial Services Advisors’s Portfolio VIRX Stock Details VIRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,904
Closed -$42K – 2858
2020
Q1 		$42K Buy
+2,904
New +$42K ﹤0.01% 2314